An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Status:
Enrolling by invitation
Trial end date:
2029-01-01
Target enrollment:
Participant gender:
Summary
Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in
Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement